The state-of-the-art Cavro Centris Pump is now available with a range of glass syringes and plastic valves to complement the existing portfolio of long-life ceramic components.
Tecan attended the 2012 SLAS Asia Conference and Exhibition at the Grand Hyatt Shanghai, China, from 19th to 21st of June 2012.
Scientists at the National Institute of Molecular Genetics in Italy rely on the Freedom EVO® platform for automated diagnostic screening of sera from patients suffering from autoimmune diseases.
Researchers in the Synthetic Biology Center at the Massachusetts Institute of Technology are using a Freedom EVO® workstation to aid the development of genetic circuits. By automating the laborious liquid handling protocols, the platform has increased throughput from just a few samples to hundreds of experiments a day.
Tecan and the Integrated BioBank of Luxembourg (IBBL) have successfully co-developed an automated platform for buffy coat extraction based on a Freedom EVO® 200 workstation, relieving scientific staff from this time-consuming task and significantly increasing the yield of DNA.
Osaka University’s International Drug Discovery Incubation Group opened its doors to drug discovery researchers in western Japan in April 2011, providing access to high throughput technologies including Tecan’s Freedom EVO® liquid handling workstations and Infinite® M1000 microplate reader.
Isogenica provides peptide, protein and antibody discovery and design services to pharmaceutical and biotechnology companies, and has invested in two Freedom EVO® liquid handling platforms to increase its capacity for the selection of next generation molecules.
In the last edition of the Tecan Journal we announced the winner of the Tecan Award 2011, Svenja Kristina Holle from the University Hospital of Münster, whose team has developed an ex vivo method for investigating the dynamics of organic cation transport in proximal tubules of the kidney, using an Infinite® 200 PRO microplate reader.
TES Pharma is a specialist biotechnology company which performs molecular, cellular and ADME screening for drug discovery. The Company has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research.
Delegates from blood centers across China recently enjoyed a visit to Tecan’s European development facilities in order to share their experiences and give their input on performing high quality ELISAs within blood banking laboratories.